Photocure ASA – Extraordinary general meeting held
Oslo, Norway, 19 June 2019: Photocure ASA (OSE: PHO), held an extraordinary general meeting on 19 June 2019 at 16:00 hours (CET).
The general meeting elected Einar Antonsen and Tove Lied Ringvold as new members of the board. Please also see minutes from the extraordinary general meeting attached.
For further information, please contact:
CFO Erik Dahl
Tel: +47 450 55 000
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com or www.cysview.com.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.